1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Novo A Buys OrthoPediatrics Corp, Glaukos Corp, Sells AnaptysBio Inc, Flexion Therapeutics Inc, Reata Pharmaceuticals Inc

Investment company Novo A buys OrthoPediatrics Corp, Glaukos Corp, sells AnaptysBio Inc, Flexion Therapeutics Inc, Reata Pharmaceuticals Inc, KalVista Pharmaceuticals Inc, Apollo Endosurgery Inc during the 3-months ended 2017-12-31, according to the most recent filings of the investment company, Novo A. As of 2017-12-31, Novo A owns 13 stocks with a total value of $706 million. These are the details of the buys and sells.

For the details of Novo A's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Novo+A

These are the top 5 holdings of Novo A
  1. Inogen Inc (INGN) - 3,549,320 shares, 59.83% of the total portfolio.
  2. Acceleron Pharma Inc (XLRN) - 1,553,937 shares, 9.34% of the total portfolio.
  3. Dermira Inc (DERM) - 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%
  4. Corvus Pharmaceuticals Inc (CRVS) - 3,244,046 shares, 4.76% of the total portfolio.
  5. Akebia Therapeutics Inc (AKBA) - 2,225,000 shares, 4.68% of the total portfolio. Shares added by 17.88%
New Purchase: OrthoPediatrics Corp (KIDS)

Novo A initiated holding in OrthoPediatrics Corp. The purchase prices were between $17.5 and $21.82, with an estimated average price of $19.11. The stock is now traded at around $17.26. The impact to a portfolio due to this purchase was 1.03%. The holding were 379,014 shares as of 2017-12-31.

New Purchase: Glaukos Corp (GKOS)

Novo A initiated holding in Glaukos Corp. The purchase prices were between $24.5 and $36.01, with an estimated average price of $29.8. The stock is now traded at around $31.75. The impact to a portfolio due to this purchase was 0.57%. The holding were 156,429 shares as of 2017-12-31.

Sold Out: AnaptysBio Inc (ANAB)

Novo A sold out a holding in AnaptysBio Inc. The sale prices were between $35 and $100.8, with an estimated average price of $73.45.

Sold Out: Flexion Therapeutics Inc (FLXN)

Novo A sold out a holding in Flexion Therapeutics Inc. The sale prices were between $19.62 and $29.93, with an estimated average price of $24.46.

Sold Out: Reata Pharmaceuticals Inc (RETA)

Novo A sold out a holding in Reata Pharmaceuticals Inc. The sale prices were between $22.39 and $33.27, with an estimated average price of $27.94.

Sold Out: KalVista Pharmaceuticals Inc (KALV)

Novo A sold out a holding in KalVista Pharmaceuticals Inc. The sale prices were between $6.8 and $13.54, with an estimated average price of $10.41.

Sold Out: Apollo Endosurgery Inc (APEN)

Novo A sold out a holding in Apollo Endosurgery Inc. The sale prices were between $3.97 and $5.69, with an estimated average price of $4.55.



Here is the complete portfolio of Novo A. Also check out:

1. Novo A's Undervalued Stocks
2. Novo A's Top Growth Companies, and
3. Novo A's High Yield stocks
4. Stocks that Novo A keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


HOLKLSUTop 20 Group Q3 2018 SHUT Sect
david.paige1stock%20screener%202.0
HOLKLSUEquity Income Group Q3 2018 SH
blovedayBest Backtest Results
muhua.huangmaster
mathew94Penny
mathew94Earning1Month
ralphdQuality Growth
salvatore34stock screener 2.0
DBrizanall 19SEP2018 942P
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK